蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 1444|回复: 2
收起左侧

【讨论】FDA says products recalled by compounder are contaminated

[复制链接]
药徒
发表于 2014-2-15 12:04:23 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
The FDA has been inspecting the largest compounding pharmacies and in December said it had concerns about the sterility of calcium gluconate 10% injections made by Rx Formulations of Mesa, AZ. The FDA now says testing has confirmed those concerns.
Rx Formulations voluntarily recalled the products in December, but the agency wants to make sure doctors and patients get the message. The agency issued a MedWatch announcement saying that the testing identified gram-positive rod bacteria in the injections. It pointed out that the contamination puts patients at risk for serious infections or reactions.
The FDA understands the potential dangers contaminated drugs pose. In November, Congress passed the Drug Quality and Security Act in response to the 2012 fungal meningitis outbreak, tied to a compounder, that sickened more than 750 people, 64 fatally. The FDA was criticized for not having a better handle on compounders, some of which have grown significantly in recent years as hospitals and doctors sought new sources for drugs that were in short supply. Some of the companies have extensive sales forces and distribute drugs on a national basis. It asked Congress for more oversight powers to keep a closer watch on the bigger operators.
The new law defined and broadened the FDA's oversight of compounders, but instead of giving the agency absolute powers, it allows compounders to volunteer for FDA oversight, to set themselves apart from the pack. The law also makes clear the FDA can inspect and take action against companies that don't volunteer if it believes there is a safety issue. Congress created the voluntary program with the idea that hospitals would want to buy from regulated companies with an FDA seal of approval.
Rx Formulations is not on the FDA's posted list of companies that have agreed to more oversight, but 24 sites, including multiple sites from some companies, have signed up. To be part of the program, the so-called outsourcing facilities must register with the FDA, agree to routine inspections and report adverse events associated with their products. They also pay a fee.
- here's the FDA MedWatch announcement
- see the FDA registration list
Related Articles:
11 compounders tell the FDA to bring it on
U.S. approves drug tracking, compound pharmacy oversight law
Compounding pharmacies: Massachusetts closes 2, FDA fights with 1 in Texas
Read more: FDA says products recalled by compounder are contaminated - FiercePharma Manufacturing http://www.fiercepharmamanufactu ... 02-11#ixzz2tFX4jNsF
Subscribe at FiercePharma Manufacturing
回复

使用道具 举报

药徒
 楼主| 发表于 2014-2-15 12:13:48 | 显示全部楼层
我是真正的蒲公英zhulikou431,其他纯属假冒伪劣,我绝不灌水。
回复

使用道具 举报

药徒
发表于 2014-2-15 13:16:03 | 显示全部楼层
compounder是私人药房吧,自己配药卖的。不知道理解是否正确。
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2026-3-11 09:18

Powered by Discuz! X3.4

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表